Company Email Format Management

Maze Therapeutics

Biotechnology Research 171 Oyster Point Blvd 146 employees

Employees: 146
Contacts: 4
Emails: 4
Phones: 2

mazetx.com LinkedIn Crunchbase

Maze Therapeutics Overview

Headquarters: 171 Oyster Point Blvd
Website: mazetx.com
Industry: Biotechnology Research
Employees: 146
Founded: 2018
Funding: 115.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Maze Therapeutics

Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease. Maze is based in South San Francisco.

Maze Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Maze Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Atul Dandekar	Chief Strategy & Business Officer	South San Francisco, California, United States	Email
Andrew Good		Redwood City, California, United States	Email
David Gao	Vice President of Technical Operations	San Francisco Bay Area, United States	Email Phone
Amy Bachrodt		South San Francisco, California, United States	Email Phone